WebbST3GAL6-AS1 (ST3GAL6 Antisense RNA 1) is an RNA Gene, and is affiliated with the lncRNA class. Diseases associated with ST3GAL6-AS1 include Myeloma, Multiple . Additional gene information for ST3GAL6-AS1 Gene HGNC (40828) NCBI Entrez Gene (100874207) Ensembl (ENSG00000239445) Alliance of Genome Resources Search for … Webb21 feb. 2003 · Sialyltransferases, such as ST3GAL6, catalyze the transfer of sialic acid from cytidine 5-prime monophospho-N-acetylneuraminic acid (CMP-NeuAc) to terminal positions of glycoprotein and glycolipid carbohydrate groups.
Theranostics: is it really a revolution? Evaluating a new term in ...
WebbHallmark gene. This gene does not have a cancer hallmark. You can see more information about hallmarks. COSMIC gene. ST3GAL6 (COSG613264) Genomic coordinates. 3:98732704..98795845 (positive strand) Synonyms. SIAT10, ST3GALVI, CCDS74968.1, ENSG00000064225.12, NM_001271145.1, NP_001258074. WebbContact Us 1-800-782-2623. Theranostics is a new approach to cancer care that combines the words “diagnostics” and “therapeutics.”. Theranostics uses molecular imaging tests, like positron emission tomography (PET), to identify cancer cells — even tiny deposits of cells. Then, radiopharmaceutical medications target the cancer cells ... popshop facebook
Identification of glycogene-type and validation of ST3GAL6
WebbAnti-ST3GAL6 antibody produced in rabbit Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution; Synonyms: Anti-SIAT10,Anti-ST3 beta-galactoside alpha-2,3-sialyltransferase 6,Anti-ST3GALVI; find Sigma-Aldrich-HPA018792 MSDS, related peer-reviewed papers, technical documents, similar … WebbTheranostics is described by some as the therapeutic equivalent of a ‘smart homing missile’ to seek and destroy cancer cells.It is an innovative approach using peptide receptor radionuclide therapy (PRRT) to seek out and destroy cancer cells. Webb25 aug. 2024 · 15. Dalangood S, Zhu Z, Ma Z, Li J, Zeng Q, Yan Y, et al. Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer. Theranostics (2024) 10:10078–91. doi: 10.7150/thno.48711. PubMed Abstract CrossRef Full Text Google Scholar pop shop florida